The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 3 863-869
Copyright © 1998 by The Endocrine Society
Rates of Cell Proliferation in Adenomatous, Suppressed, and Normal Parathyroid Tissue: Implications for Pathogenesis1
A. M. Parfitt,
Q. Wang and
S. Palnitkar
Bone and Mineral Division, Henry Ford Hospital, Detroit, Michigan
48202
Address all correspondence and requests for reprints to: A. M. Parfitt, M.D., Department of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot 587, Little Rock, Arkansas 72205-7199.
 |
Abstract
|
|---|
In previous studies, the birth rate of new cells in parathyroid
adenomas measured at the time of surgical excision was shown to be much
too low to account for growth of the tumors from a single cell in the
time available, but comparison with normal rates was not possible. We
measured the prevalence of cells expressing the Ki-67 antigen, a cell
cycle marker, in 55 parathyroid adenomas using the MIB-1 antibody and
microwave antigen retrieval; in 22 cases, separate measurements were
made in nonadenomatous tissue from the same glands. In 10 cases
complete maps of the gland profile were reconstructed to study the
distribution of labeled cells. The proportion of Ki-67-positive cells,
estimated by systematic random sampling, was used to calculate cell
birth rate assuming a duration of Ki-67 expression of 24 h; the
results were compared to rates previously determined in normal
parathyroid glands by the same method. The geometric mean cell birth
rate was 9.97%/yr, about double the normal rate of 5.4%/yr, but less
than a third of the cases had values above the normal range. The
corresponding value in nonadenomatous tissue was 2.58%/yr, about half
the normal rate. In 10 cases studied in more detail, the cell birth
rate was 12.3%/yr in the peripheral regions and 6.2%/yr in the
central regions, a value not significantly different from normal. The
results in adenomas are in reasonable agreement with previous estimates
of cell birth rate of 13.7%/yr using [3H]thymidine
labeling and 6.4%/yr using prevalence of the mitotic karyotype. The
proportion of Ki-67-positive cells using unbiased sampling was about 50
times smaller than that in previous studies using selective sampling.
Cell birth rates at the time of excision were about 2025 times lower
than initial rates estimated from modeling tumor growth by the Gompertz
function. We conclude that 1) cell birth rate in parathyroid adenomas
has fallen substantially during the growth of the tumors and is only
modestly greater than normal; 2) the fall in cell birth rate had been
greater in the central and presumably older regions of the adenoma than
in the peripheral and presumably younger regions; 3) nonadenomatous
tissue was suppressed with respect to its proliferative as well as its
secretory function, presumably as a result of hypercalcemia; and 4) the
progressive fall in cell birth rate, despite the accumulation of
mutations that are supposed to increase cell birth rate, is most
readily explained by the set-point hypothesis.
 |
Introduction
|
|---|
IN MOST patients with primary
hyperparathyroidism discovered by multichannel biochemical screening,
which is the most common manner of presentation in current practice,
the clinical and biochemical course is nonprogressive (1), suggesting
that by the time of diagnosis, the parathyroid tumor net growth rate
has become very slow (2). Furthermore, the birth rate of new cells
measured at the time of surgical excision is much too low to account
for growth of the tumors from a single cell in the time available,
indicating that cell birth rate must have declined substantially during
the lifespan of the tumor (3, 4). In accordance with these
observations, parathyroid cell proliferation and tumor growth as
functions of time can be successfully modeled by the Gompertz function,
with much closer approach to the asymptotic values than when this
function is used to model the growth of malignant tumors (5).
Parathyroid adenoma cell birth rates measured by tritiated thymidine
labeling (3) or by the prevalence of the mitotic karyotype (4) cannot
be related to the rates in normal parathyroid tissue because the
necessary data are unavailable. The Ki-67 antigen has a short
half-life, labels only cycling cells (6), and with the MIB-1 antibody
and microwave antigen retrieval can be applied to archival tissue (7).
Using this method, we have recently reported a geometric mean cell
birth rate for normal human parathyroid glands of about 5%/yr (8),
demonstrating the parathyroid gland to be a conditional renewal tissue
of very low turnover (9, 10). Values for abnormal cell proliferation
can now be compared for the first time with normal values obtained by
the same method, and we report the application of this method to
parathyroid adenomas and to presumably suppressed nonadenomatous tissue
in the same glands. We found significant differences, but also
substantial overlap, among the three types of tissue. We discuss the
results in relation to concepts of parathyroid tumor pathogenesis in
general and the set-point hypothesis in particular (2, 3, 4, 5).
 |
Subjects and Methods
|
|---|
Patients
We studied 55 patients with primary hyperparathyroidism due to a
single adenoma. Eighteen patients (group A) were selected because they
had been under the care of one of the authors (A.M.P.) between 1972 and
1980, and detailed records were available. Thirty-seven patients (group
B) were selected because fresh parathyroid tissue had been harvested
between 1992 and 1995 for the study of cell proliferation by
bromodeoxyuridine incorporation, a method subsequently found to be
unsatisfactory. Demographic and biochemical data in the two groups are
compared in Table 1
. In group B, the mean
age was higher, and there were relatively more male and fewer black
patients, but these differences were not significant. The mean plasma
calcium level was lower in group B; this might have reflected a change
in case-finding methods or in criteria for surgical referral, but the
ranges were similar. Also, because of a change in method, the reference
range was lower than that during the earlier period. Mean plasma
phosphate and creatinine levels did not differ between the groups. In
group B, the mean intact PTH level (11) was 126 (SD = 91)
pg/mL, with reference values of 1058. PTH was not measured in most
patients in group A. In group B, mean total alkaline phosphatase,
measured by automated analysis (12), was 117 (SD = 46)
IU/L, with reference values of 2783. In many patients in group A,
alkaline phosphatase had been measured only by the Bodansky method.
Histologic procedures
Paraffin-embedded blocks were retrieved, and new sections of 5
µm thickness were cut; one was stained with hematoxylin and eosin,
and the others were used for either proliferating cell nuclear antigen
(PCNA) (7, 13) or Ki-67 (7, 8, 14) immunohistochemistry. After
deparaffinization, the slides were incubated for 5 min in 3% hydrogen
peroxide to block endogenous peroxidase. For PCNA, the slides were
rinsed in phosphate-buffered saline, covered with 5% horse serum for
40 min, and incubated for 1416 h overnight at 4 C with a 1:1500
dilution of monoclonal antibody to PCNA (DACO clone PC10). For Ki-67,
the slides were transferred to plastic Coplin jars filled with 10
mmol/L citrate buffer (pH 6.0) and heated in a microwave oven twice for
5 min each time at a power of 1080 watts. After cooling at room
temperature for 15 min, the slides were covered with 5% horse serum
for 40 min and incubated overnight at 4 C with 1:100 MIB-1 monoclonal
antibody (Immunotech, Westbrook, ME; catalogue no. 0505). For both PCNA
and Ki-67, the slides were treated with biotinylated horse antimouse
IgG for 30 min, followed by incubation with peroxidase-conjugated
streptavidin for 60 min. Finally, the slides were developed for 5 min
with 3-amino-9-ethyl carbazole (Sigma Chemical Co., St. Louis, MO). The
mean specimen age was 21.8 yr for group A and 1.9 yr for group B. In
each batch, new sections of human tonsil were used as a positive
control (8). The sections were derived from two different blocks that
had been treated in exactly the same way and had a mean specimen age of
2.0 yr.
Microscopic procedures
In each section, the gland profile was divided whenever possible
into adenoma and nonadenoma tissue, using standard criteria (15). Each
tissue type was subdivided into 2, 3, or 4 regions depending on size.
In the adenomas, at least 20 fields were selected by systematic random
sampling (16) at x40 magnification. Using an eyepiece graticule with
an unbiased square counting frame with 100 test points, the number of
positive cells was counted in 1 large square (=100 small squares) and
the total number of chief cells was counted in 1 small square at x200
magnification. All cell profiles with any portion inside the frame,
provided they did not touch or intersect the exclusion edges or their
extensions, were counted (16). Only strongly staining chief cell nuclei
without cytoplasmic staining were considered positive cells. In some
cases, total chief cells were counted in the corresponding field of the
adjacent hematoxylin- and eosin-stained section. The procedure was
continued in each case until at least 150 total chief cells had been
counted in small squares, corresponding to 15,000 cell profiles in the
large squares. If no positive cell was found, a value of 0.5,
equivalent to half the detection limit, was assigned (4). Results were
expressed as the labeling index (LI) = positive cells/10,000 cells.
In 10 cases, all from group B, not differing in any feature from the
other 27 cases, the entire adenoma profile in Ki-67-stained sections
was examined. By systematically moving the stage row by row, the
eyepiece graticule and counting frame were superimposed successively on
adjacent square fields. In each counting frame, both total and positive
cells were recorded as previously described, and the distribution of
positive cells in the entire tumor was reconstructed (8). At the
periphery of the tumor profile, fields in which fewer than 50 of the
small squares overlay the tissue section were disregarded. The
reconstructed map of the section was divided into outer and inner
regions (8).
Calculation of cell birth rate and life span
For reasons given below, only Ki-67 data were used for these
calculations. The Ki-67 antigen is expressed in all stages of the cell
cycle, but decays rapidly, with a half-life of less than 1 h and
so becomes undetectable very soon after the completion of mitosis (6).
The fraction of Ki-67-positive cells is the same as the average
fraction of time that each cell spends in the cycling, rather than in
the noncycling (G0), state (17). The duration of the cell
cycle in the parathyroid gland has never been measured, but a
representative mean value for nonneoplastic cells in a variety of
tissues and species is 24 h; the majority of values fall between
1832 hs (9, 10). With this assumption: mean cell birth rate (%/yr) =
LI (/10,000) x 365/10,000 x 100 = LI x 3.65. If the
current cell birth rate were to be maintained, the corresponding mean
cell life span (years) would be 100/(LI x 3.65). For such
growth-related variables and for gland weight, the geometric mean was
calculated as exp (mean loge x), and the
geometric (multiplicative) SD was calculated as exp
(SD loge x).
Statistics
Differences between tissue types were evaluated initially by
one-way ANOVA, followed by appropriate pairwise comparison, and
differences between groups and regions were determined by unpaired or
paired Students t tests as appropriate. Relations between
variables were tested by linear regression analysis. Nonparametric
methods were used when indicated. The frequency distribution of
positive cells among different graticule fields was compared with the
expected Poisson distribution by computation of the
2
value (18).
 |
Results
|
|---|
The primary data are given in Table 2
. The LI was significantly higher for
PCNA than for Ki-67 (P = 0.002), although there was a
significant correlation between the two measurements (r = 0.53;
P < 0.001). Because positive and negative cells are
more easily distinguished and for other reasons described below,
further analysis was restricted to the Ki-67 results. The Ki-67 LI was
significantly lower in group A than in group B adenomas, presumably
because loss of antigen during prolonged storage of the blocks was
refractory to microwave retrieval. For the entire series, there was a
significant regression of LI on specimen age (Ln LI = 1.00 -
0.0457 x specimen age; r = -0.32; P =
0.017), and this regression was used to correct all LI values to a
specimen age of zero (corrected Ln LI = observed Ln LI +
0.0457 x specimen age). In nonadenomatous tissue, there was no
difference in Ki-67 LI between group A and group B and no significant
regression on specimen age. This difference might reflect smaller
sample size or stronger expression in normal than in abnormal tissue
and consequent lesser susceptibility to decay with time. The
age-corrected LI was almost 4 times higher in the adenomas than in the
nonadenomatous tissue, and there was no significant correlation between
the LI values.
Because of similar clinical and biochemical characteristics and almost
identical mean values for gland weight, the groups were combined. There
was no significant correlation between corrected log LI, and patient
age, total gland weight, or total plasma calcium. The results were the
same for analysis restricted to group B, and there was no correlation
with PTH. The specimen age-corrected values were used for calculation
of cell birth rate and cell life span, and these values are compared
with those in nonadenomatous tissue and in normal parathyroid tissue
(8) in Table 3
. There were significant
differences among the three types of tissue. The cell birth rate was
about twice normal in the adenomas and about half normal in the
nonadenomatous tissue. The rates conformed to a log normal distribution
with very wide ranges and substantial overlap (Fig. 1
). Only nine adenomas had values above
the 95% confidence interval for the normal glands (expected number,
1.4), and only 16 (29%) had values above the corresponding range. Only
one nonadenomatous value was below the 95% confidence interval for the
normal glands, and only three were below the corresponding range.

View larger version (13K):
[in this window]
[in a new window]
|
Figure 1. Individual values for cell birth rate in
three types of parathyroid tissue, plotted on a logarithmic scale.
Horizontal lines identify geometric means and ranges
corresponding to two multiplicative SD (values in
parentheses) on either side of the mean.
|
|
Results in the 10 cases in which maps of the entire tumor were
reconstructed are given in Table 4
. A
total of 473 Ki-67-positive cells were found in approximately 1,243,000
total chief cells. The Ki-67 LI and calculated cell birth rate were
significantly higher by about 2-fold in the peripheral than in the
central regions, in which the rates did not differ significantly from
normal. The frequency distribution of number of positive cells per
field showed significantly more fields than expected with no labeled
cells, or more than two labeled cells (Table 5
). The values for the entire tumor did
not differ from the values previously obtained by the less rigorous
method and were very similar to the values for the whole series based
on random sampling, although the variability was lower because of
greater precision. The mean number of cell profiles per graticule field
in different subjects ranged from 399-1702; the mean of 905 was not
significantly different from the value of 1178 cells/graticule field in
normal glands (8), but the variability between fields and between
subjects was greater. If, in each case, only the fields with the most
positive cells had been counted, the arithmetic mean label index would
have been 29.4 instead of 3.6/10,000 cells, an 8-fold overestimation.
If x400 rather than x200 magnification had been used, the referent
cell number would have been reduced 4-fold, and the bias would have
been increased an additional 4-fold.
 |
Discussion
|
|---|
For many years, the standard method for studying cell
proliferation was based on the uptake of tritiated thymidine by cells
in S phase. This method was the first to be applied to the parathyroid
gland (19), but is cumbersome and requires great care to ensure cell
viability during the incubation of freshly harvested tissue; the same
disadvantages apply to the use of bromodeoxyuridine as an S phase
marker (20). Less technically demanding are methods based on
information already present in the nucleus, obviating the need for
administration of an exogenous label. The most widely used has been the
mitotic karyotype (21), but because of the very short duration of
mitosis, positive cells are extremely infrequent in low turnover
tissues (4). Several new cell cycle markers with advantages over the
mitotic karyotype have been developed (7, 20, 22), of which PCNA has
been most often applied to the parathyroid gland (23, 24, 25).
Unfortunately, PCNA expression overestimates the proportion of cycling
cells. Because of its long half-life, it is detectable for a
considerable time after completion of mitosis (7), and it is expressed
during DNA repair as well as during cell division (7, 26). We found the
proportion of PCNA-positive cells to be about double the proportion of
Ki-67-positive cells, based on median values. An even greater
difference of about 3-fold has previously been reported in abnormal
parathyroid tissue (24).
The prevalence of cell cycle markers has usually been used as a
diagnostic and prognostic tool in patients with neoplasia (7, 20, 21, 22)
and much less often to study rates of cell proliferation. Until
recently, it was standard practice in diagnostic histopathology to
express the prevalence of cell cycle markers per high power field, but
because the areal density of cell profiles is so variable, it is much
more satisfactory to use a defined number of cell profiles as the
referent (27); in the present study, the number of cells per graticule
field varied over more than a 4-fold range between patients. The
interpretation of data concerning cell cycle markers depends heavily on
the method of sampling within the section. In diagnostic work it has
been usual to make measurements only in the most heavily labeled
regions of the section (20). In the present study, this procedure would
have overestimated the proportion of labeled cells and the calculated
cell birth rate by at least 8-fold, and possibly much more, depending
on the magnification used (8). We avoided this bias and estimated even
very low prevalence values without unreasonable expenditure of time by
using a much smaller graticule area to estimate the referent cell
profile number than to count the positive cells (16).
The calculation of cell birth rate and life span assumed a duration of
Ki-67 expression of 24 h, an assumption previously justified in
detail (28). If the duration of expression is shorter, the calculated
cell birth rate would be higher and vice versa. The duration
of the cell cycle is generally longer in malignant tumors than in
normal tissue (10). If this applied also to parathyroid adenomas, the
difference in cell birth rate would be even smaller than we have
calculated. In previous work, the geometric mean rate of cell
proliferation was estimated to be 13.7%/yr in sporadic parathyroid
adenomas, assuming the duration of S phase to be 12 h (3), and
6.4%/yr in radiation-associated parathyroid adenomas, assuming the
duration of mitosis to be 0.5 h (4). Thus, three independent
methods, all using an appropriate sampling procedure, have produced
results that varied over little more than a 2-fold range. Considering
the uncertainties in the estimates of the durations of various
subdivisions of the cell cycle, this is reasonable agreement. Fresh
tissue (3) may have given higher results than archival tissue (4)
(Table 4
) because of unrecognized changes during tissue processing and
storage. It is also possible that the rates are indeed somewhat lower
in radiation-associated than in sporadic adenomas (4), and that such
tumors are closer to their growth asymptote (5).
The proportion of Ki-67-positive cells was approximately 50 times
smaller in the present study than in studies that used selective and
consequently biased sampling (Table 6
)
(29, 30). The similarity in LI results when the whole section was
examined (2.89 vs. 2.72) demonstrates that our sampling was
unbiased. We believe that our detection method has been well validated
(8, 28) and that the absence of sampling bias is the most likely
explanation for our lower results. Very high results despite less
biased (although nonrandom) sampling probably reflect an unusually
sensitive method for PCNA that detected more cells undergoing DNA
repair (25). Even higher values for the proportion of cycling cells are
given by flow cytometry (Table 6
) (31), but this method is not
applicable to low turnover tissue, partly because of cellular debris
(32) and partly because of inability to distinguish between the
elective tetraploidy of cells that have completed S phase and
constitutive tetraploidy. This is a feature of many normal tissues (2)
and of tumors of several endocrine glands, including the parathyroid
(33, 34).
One of the traditional histological criteria for parathyroid adenoma is
an adjacent rim of normal or more strictly nonadenomatous tissue (15).
Based on physiological reasoning and ultrastructural features
suggesting inhibition of PTH secretion (35), such tissue is generally
assumed to be suppressed with respect to its secretory activity.
Consistent with this conclusion, the secretory set-point determined
in vitro in cells harvested from other glands is reduced
below normal (36). We have demonstrated that nonadenomatous tissue is
suppressed with respect to its proliferative as well as its secretory
activity, confirming a recent report (25). This is a further example of
the close link between these two aspects of parathyroid cell function
(2), a link that is probably characteristic of all endocrine glands
(37). A reduction in cell birth rate by 50% together with the
persistence of apoptosis at the same rate would explain the small, but
significant, reduction in the weight of nonadenomatous glands in
patients with parathyroid adenoma (38, 39).
We found a significantly higher proportion of cycling cells in the
peripheral than in the central regions of parathyroid adenomas and a
significant deviation from random distribution. By contrast, in normal
parathyroid glands, there is no difference between peripheral and
central regions and close conformity to a Poisson distribution (8). A
clustered distribution of cycling cells has been reported in nodular
secondary hyperparathyroidism and also in some parathyroid adenomas
(24), although this conclusion was based on simple inspection of the
sections rather than on statistical evaluation. We did not find such
clusters (indeed, the largest number of cycling cells in any graticule
field was six), but, rather, observed a general tendency for cell birth
rate to be higher closer to the perimeter of the tumors. In a large,
rapidly growing, malignant tumor, the central region may be relatively
ischemic and hypoxic (40), but there is no reason to suppose that blood
supply would be compromised in the center of a small, slowly growing,
benign tumor of a highly vascular tissue (41), and there was no
histological evidence for such a phenomenon. A differential cell birth
rate appears to be a characteristic of parathyroid tumor growth, for
which an explanation is required.
It was previously demonstrated (3, 4) that cell birth rates in
parathyroid adenomas had declined substantially during their life span,
assuming that they arose from a single mutant cell. In
radiation-associated adenomas, the initial cell birth rate can be
estimated by fitting the data to the Gompertz function (5). The
geometric mean and 95% confidence limits of these estimated rates are
compared with observed rates at the time of excision in Table 7
. For this purpose, data in the 10
completely mapped cases were used, because the precision of individual
values was greater and the range narrower. The estimated decline in
cell birth rate, based on geometric means, was 20- to 25-fold, but the
ranges were very wide, so that the extent of decline could have varied
substantially between cases. Because of the differential cell birth
rate previously discussed (Table 4
), the decline had been greater in
the center than in the periphery of the tumor. Tumors enlarge mainly by
interstitial growth, a process that must be accompanied by cell
displacement, but it is reasonable to assume that the mean age of cells
is greater in the center than in the periphery, which suggests that the
magnitude of decline in cell birth rate in parathyroid adenomas is a
function of cell age.
The preceding argument highlights a central paradox in the pathogenesis
of parathyroid adenomas. The prevailing paradigm of neoplasia is that
abnormal cells accumulate a succession of mutations, each of which
confers an additional growth advantage, a process known as clonal
evolution (2, 42). This paradigm is widely believed to apply to
endocrine tumors in general and to parathyroid adenomas in particular
(43, 44). A high proportion of these tumors harbor at least one of a
large number of different mutations, including activation of the
putative protooncogene cyclin D1 (45), and allelic losses at multiple
sites, each consistent with the loss or inactivation of a different
tumor suppressor gene (44). However, during a process that supposedly
leads to a progressive increase in the rate of cell division, the rate
is progressively declining. Furthermore, the cells that have had the
longest time to accumulate mutations have the lowest rate of cell
division, a rate that is no longer significantly greater than normal.
Another difficulty (2) is to reconcile the frequent occurrence of
mutations with rates of cell division that are at least 10 times lower
than those in meningiomas, the only other benign tumors for which
adequate data are available (4), and up to 1000 times lower than those
in malignant tumors (10).
One way out of this dilemma, the only way in our opinion, is provided
by the set-point hypothesis. It is proposed (2, 3, 4, 5, 8, 46) that a
hereditary change in phenotype occurs in a single cell that decreases
its sensitivity to its ambient calcium concentration. This change does
not result from a mutant form of the serpentine calcium sensing
receptor (47, 48), but could result from a reduction in the number of
normal receptors (49), which is the main determinant of the secretory
set-point (50). By whatever means the change in sensitivity was brought
about, the abnormal cell would behave in the same way as a normal cell
exposed to hypocalcemia. It would increase its rate of PTH secretion,
but to no avail, and eventually would be driven to divide. The clone of
new cells would continue to proliferate, but ever more slowly, until it
was large enough to raise the patients plasma calcium level to the
new secretory set-point. Because of the very long time interval between
successive divisions, the decline in cell birth rate would be very slow
and would have progressed further in older cells (Table 4
). The
increase in cell proliferation in the early stages of tumor growth
would increase the mutagenic risk (51), and so set the stage for the
mutations that have been detected. Although not yet supported by direct
evidence, the set-point hypothesis accounts for the current clinical
characteristics of primary hyperparathyroidism, the main abnormality in
PTH secretion, the low rates of cell proliferation at the time of
surgical excision, the difference in cell birth rate between the
central and peripheral regions, the inferred pattern of asymptotic
growth, and the high prevalence of mutations, all by means of a single
mechanism.
 |
Acknowledgments
|
|---|
We thank Gary Talpos for provision of fresh parathyroid tissue,
Richard Zarbo for access to archival specimens, Raouf Nakhleh for
assistance with immunohistological methods, Paula Dillon for section
preparation, Paula Roberson for assistance with statistical analysis,
and Constance Mott for preparation of the manuscript.
 |
Footnotes
|
|---|
1 This work was supported by NIH Grant PO1-AG/AR-13918 and the Breech
Endowment of the Bone and Joint Center, Henry Ford Hospital. 
Received February 4, 1997.
Revised September 4, 1997.
Revised November 24, 1997.
Accepted December 4, 1997.
 |
References
|
|---|
-
Parfitt AM, Rao DS, Kleerekoper M. 1991 Asymptomatic primary hyperpara-thyroidism discovered by multi-channel
biochemical screening. Clinical course and considerations bearing on
the need for surgical intervention. J Bone Miner Res.
6:S97S101.
-
Parfitt AM. 1994 Parathyroid growth: normal and
abnormal. In: Bilezikian JP, ed. The parathyroidsbasic and clinical
concepts. New York: Raven Press; 373405.
-
Parfitt AM, Willgoss D, Jacobi J, Lloyd HM. 1991 Cell kinetics in parathyroid adenomas: evidence for decline in rates of
cell birth and tumour growth, assuming clonal origin. Clin Endocrinol
(Oxf). 35:151157.[Medline]
-
Parfitt AM, Braunstein GD, Katz A. 1993 Radiation-associated hyperparathyroidism: comparison of adenoma growth
rates, inferred from weight and duration of latency, with prevalence of
mitosis. J Clin Endocrinol Metab. 77:13181322.[Abstract]
-
Parfitt AM, Fyhrie DP. Gompertzian growth curves
in parathyroid tumors: further evidence for the set point hypothesis.
Cell Prolif. In press.
-
Duchrow M, Gerdes J, Schluter C. 1994 The
proliferation-associated Ki-67 protein: definition in molecular terms. Cell Prolif. 27:235242.[Medline]
-
Yu CC-W, Filipe MI. 1993 Update on
proliferation-associated antibodies applicable to formalin-fixed
paraffin-embedded tissue and their clinical applications. Histochem J. 25:843953.[Medline]
-
Wang Q, Palnitkar S, Parfitt AM. 1997 The basal
rate of cell proliferation in normal human parathyroid tissue:
implications for the pathogenesis of hyperparathyroidism. Clin
Endocrinol (Oxf). 46:343349.[CrossRef][Medline]
-
Wright N, Alison M, eds. 1984 The biology of
epithelial cell populations. Oxford: Clarendon Press.
-
Baserga R. 1985 The biology of cell reproduction.
Cambridge: Harvard University Press.
-
Nussbaum SR, Potts Jr JT. 1991 Immunoassays for
parathyroid hormone 184 in the diagnosis of hyperparathyroidism.
J Bone Miner Res. 6(Suppl 2):S43S50.
-
Parfitt AM, Podenphant J, Villanueva AR, Frame B. 1985 Metabolic bone disease with and without osteomalacia after
intestinal bypass surgery: a bone histomorphometric study. Bone. 6:211220.[Medline]
-
Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ. 1993 Prognostic value of proliferating cell nuclear antigen index in gastric
stromal tumors. Am J Clin Pathol. 100:428432.[Medline]
-
McCormick D, Chong H, Hobbs C, Datta C, Hall PA. 1993 Detection of the Ki-67 antigen in fixed and wax-embedded sections
with the monoclonal antibody MIB-1. Histopathology. 22:355360.[Medline]
-
LiVolsi VA. 1994 Embryology, anatomy, and pathology
of the parathyroids. In: Bilezikian JP, ed. The parathyroidsbasic and
clinical concepts. New York: Raven Press; 114.
-
Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Moller
A, Nielsen K, Myengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West
MJ. 1988 Some new, simple and efficient stereological methods and
their use in pathological research and diagnosis. APMIS. 96:379394.[Medline]
-
Kroll S, Char D, Kaleta-Michaels S. 1995 A
stochastic model for dual label experiments: an analysis of the
heterogeneity of S phase duration. Cell Prolif. 28:545567.[Medline]
-
Colton T. 1974 Statistics in medicine. Boston:
Little, Brown.
-
Lloyd HM, Jacobi JM, Willgoss D, Kearney J, Ward P. 1981 DNA synthesis and secretory activity in parathyroid adenomas. Acta
Endocrinol (Copenh). 96:7074.[Abstract/Free Full Text]
-
Carroll PR, Waldman FM, Rosenau W, Cohen MB, Vapnek JM,
Fong P, Narayan P, Mayall BH. 1993 Cell proliferation in prostatic
adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine
incorporation and proliferating cell nuclear antigen expression. J
Urol. 149:403407.[Medline]
-
Baak JPA. 1990 Mitosis counting in tumors. Hum
Pathol. 21:683685.[CrossRef][Medline]
-
Pelosi G, Zamboni G. 1996 Proliferation markers and
their uses in the study of endocrine tumors. Endocr Pathol. 7:103119.[Medline]
-
Kurimoto S, Moriyama N, Nagase Y, Doi N, Aso Y. 1993 Expression of proliferating cell nuclear antigen (PCNA) in human
parathyroid adenoma. Acta Histochem Cytochem. 26:391396.
-
Loda M, Lipman J, Cukor B, Bur M, Kwan P, DeLellis
RA. 1994 Nodular foci in parathyroid adenomas and hyperplasias: an
immunohistochemical analysis of proliferative activity. Hum Pathol. 25:10501056.[CrossRef][Medline]
-
Yamaguchi S, Yachiku S, Morikawa M. 1997 Analysis
of proliferative activity of the parathyroid glands using proliferating
cell nuclear antigen in patients with hyperparathyroidism. J Clin
Endocrinol Metab. 82:26812688.[Abstract/Free Full Text]
-
Shivil KK, Kenny MK, Wood RD. 1992 Proliferating
cell nuclear antigen is required for DNA excision repair. Cell;69
:367374.
-
Quinn CM, Wright NA. 1990 The clinical assessment
of proliferation and growth in human tumours: evaluation of methods and
applications as prognostic variables. J Pathol. 160:93102.[CrossRef][Medline]
-
Wang Q, Palnitkar S, Parfitt AM. 1996 Parathyroid
cell proliferation in the rat. Effect of age and of phosphate
administration and recovery. Endocrinology. 137:45584562.[Abstract]
-
Abbona GC, Papotti M, Gasparri G, Bussolati G. 1995 Proliferative activity in parathyroid tumors as detected by Ki-67
immunostaining. Hum Pathol. 26:135138.[CrossRef][Medline]
-
Lloyd RV, Carney JA, Ferreiro JA, et al. 1995 Immunohistochemical analysis of the cell cycle-associated antigens K-67
and retinoblastoma protein in parathyroid carcinomas and adenomas. Endocr Pathol. 6:279287.[Medline]
-
Chryssochoos JT, Weber CJ, Cohen C, et al. 1995 DNA
index and ploidy distinguish normal human parathyroids from parathyroid
adenomas and primary hyperplastic parathyroids. Surgery. 118:10411050.[Medline]
-
Meyer JS, Coplin MD. 1988 Thymidine labeling index,
flow cytometric S-phase measurement, and DNA index in human tumors. Am J Clin Pathol. 89:586595.[Medline]
-
Joensuu H, Klemi PJ. 1988 DNA aneuploidy in
adenomas of endocrine organs. Am J Pathol. 132:145151.[Abstract]
-
Bengtsson A, Grimelius L, Johansson H, Ponten J. 1977 Nuclear DNA-content of parathyroid cells in adenomas, hyperplastic
and normal glands. APMIS. 85:455460.
-
Wernerson A, Svensson O, Reinholt FP. 1995 Quantitative and three-dimensional aspects of the rat parathyroid gland
in normo-, hypo-, and hypercalcemia. Microsc Res Technol. 32:129147.[CrossRef][Medline]
-
Brown EM, Wilson RE, Thatcher JG. 1981 Abnormal
calcium-regulated PTH release in normal parathyroid tissue from
patients with adenoma. Am J Med. 71:565570.[CrossRef][Medline]
-
Lloyd HM, Jacobi JM, Willgoss DA. 1995 DNA
synthesis by pituitary tumours, with reference to plasma hormone levels
and to effects of bromocriptine. Clin Endocrinol (Oxf). 43:7985.[Medline]
-
Ejerblad S, Grimelius L, Johansson H, Werner I. 1976 Studies on the non-adenomatous glands in patients with a solitary
parathyroid adenoma. Ups J Med Sci. 81:3136.[Medline]
-
Parfitt AM. 1982 Hypercalcemic hyperparathyroidism
following renal transplantation: differential diagnosis, management,
and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab. 8:92119.[Medline]
-
Sutherland RM. 1986 Importance of critical
metabolites and cellular interactions in the biology of microregions of
tumors. Cancer. 58:16681680.[CrossRef][Medline]
-
Murakami T, Tanaka T, Taguchi T, Ohtsuka A, Kikuta
A. 1995 Blood vascular bed and pericapillary space in rat
parathyroid glands. Microsc Res Technol. 32:112119.[Medline]
-
Knudson AG. 1995 Mutation and cancer: a personal
odyssey. Adv Cancer Res. 67:123.[Medline]
-
Arnold A. 1994 Molecular mechanisms of parathyroid
neoplasia. Endocrinol Metab Clin North Am. 23:93107.[Medline]
-
Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. 1996 Genomic localization of novel candidate tumor suppressor gene loci
in human parathyroid adenomas. Cancer Res. 56:599605.[Abstract/Free Full Text]
-
Hsi ED, Zukerberg R, Yang W-I, Arnold A. 1996 Cyclin D1/PRAD1 expression in parathyroid adenomas: an
immunohistochemical study. J Clin Endocrinol Metab. 81:17361739.[Abstract]
-
Mallette LE. 1991 The parathyroid polyhormones: new
concepts in the spectrum of peptide hormone action. Endocr Rev. 12:110117.[CrossRef][Medline]
-
Hosokawa Y, Pollak MR, Brown EM, Arnold A. 1995 Mutational analysis of the extracellular Ca2+-sensing
receptor gene in human parathyroid tumors. J Clin Endocrinol
Metab. 80:31073110.[Abstract]
-
Thompson DB, Samowitz WS, Odelberg S, Davis RK, Szabo J,
Heath III H. 1995 Genetic abnormalities in sporadic parathyroid
adenomas: loss of heterozygosity for chromosome 3q markers flanking the
calcium receptor locus. J Clin Endocrinol Metab. 80:33773380.[Abstract]
-
Kifor O, Moore FD, Wang P, et al. 1996 Reduced
immunostaining for the extracellular Ca2+-sensing receptor
in primary and uremic secondary hyperparathyroidism. J Clin
Endocrinol Metab. 81:15981606.[Abstract]
-
Ho C, Conner DA, Pollak MR, et al. 1995 A mouse
model of human familial hypocalciuric hypercalcemia and neonatal severe
hyperparathyroidism. Nat Genet. 11:389394.[CrossRef][Medline]
-
Cohen SM. 1995 Role of cell proliferation in
regenerative and neoplastic disease. Toxicol Lett. 82/83:1521.
This article has been cited by other articles:

|
 |

|
 |
 
G. J. Strewler
A 64-Year-Old Woman With Primary Hyperparathyroidism
JAMA,
April 13, 2005;
293(14):
1772 - 1779.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Garcia de la Torre, I. Buley, J. A. H. Wass, D. G. Jackson, and H. E. Turner
Angiogenesis and Lymphangiogenesis in Parathyroid Proliferative Lesions
J. Clin. Endocrinol. Metab.,
June 1, 2004;
89(6):
2890 - 2896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Mallya, J. J. Gallagher, and A. Arnold
Analysis of Microsatellite Instability in Sporadic Parathyroid Adenomas
J. Clin. Endocrinol. Metab.,
March 1, 2003;
88(3):
1248 - 1251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Rao, M. Honasoge, G. W. Divine, E. R. Phillips, M. W. Lee, M. R. Ansari, G. B. Talpos, and A. M. Parfitt
Effect of Vitamin D Nutrition on Parathyroid Adenoma Weight: Pathogenetic and Clinical Implications
J. Clin. Endocrinol. Metab.,
March 1, 2000;
85(3):
1054 - 1058.
[Abstract]
[Full Text]
|
 |
|